{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:31:21Z","timestamp":1780587081111,"version":"3.54.1"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,2,28]],"date-time":"2007-02-28T00:00:00Z","timestamp":1172620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,2,28]],"date-time":"2007-02-28T00:00:00Z","timestamp":1172620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuroradiology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1007\/s00234-007-0216-2","type":"journal-article","created":{"date-parts":[[2007,2,27]],"date-time":"2007-02-27T15:15:46Z","timestamp":1172589346000},"page":"393-409","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Idiopathic inflammatory-demyelinating diseases of the central nervous system"],"prefix":"10.1007","volume":"49","author":[{"given":"A. Rovira","family":"Ca\u00f1ellas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Rovira","family":"Gols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. R\u00edo","family":"Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Tintor\u00e9","family":"Subirana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. Montalban","family":"Gairin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,2,28]]},"reference":[{"key":"216_CR1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.clineuro.2004.02.016","volume":"106","author":"VV Brinar","year":"2004","unstructured":"Brinar VV (2004) Non-MS recurrent demyelinating diseases. Clin Neurol Neurosurg 106:197\u2013210","journal-title":"Clin Neurol Neurosurg"},{"key":"216_CR2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jns.2004.07.003","volume":"225","author":"T Fukazawa","year":"2004","unstructured":"Fukazawa T, Kikuchi S, Niino M et al (2004) Attack-related severity: a key factor in understanding the spectrum of idiopathic inflammatory demyelinating disorders. J Neurol Sci 225:71\u201378","journal-title":"J Neurol Sci"},{"key":"216_CR3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1600-0404.1992.tb05490.x","volume":"86","author":"S Poser","year":"1992","unstructured":"Poser S, Luer W, Bruhn H, Frahm J, Bruck Y, Felgenhauer K (1992) Acute demyelinating disease. Classification and non-invasive diagnosis. Acta Neurol Scand 86:579\u2013585","journal-title":"Acta Neurol Scand"},{"key":"216_CR4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1474-4422(06)70572-5","volume":"5","author":"A Charil","year":"2006","unstructured":"Charil A, Yousry TA, Rovaris M, Barkhof F, De Stefano N, Fazekas F et al (2006) MRI and the diagnosis of multiple sclerosis: expanding the concept of \u201cno better explanation\u201d. Lancet Neurol 5:841\u2013852","journal-title":"Lancet Neurol"},{"key":"216_CR5","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","volume":"46","author":"FD Lublin","year":"1996","unstructured":"Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907\u2013911","journal-title":"Neurology"},{"key":"216_CR6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/jnnp.67.2.148","volume":"67","author":"SA Hawkins","year":"1999","unstructured":"Hawkins SA, McDonnell GV (1999) Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 67:148\u2013152","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"216_CR7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1212\/WNL.62.4.601","volume":"62","author":"SJ Pittock","year":"2004","unstructured":"Pittock SJ, Mayr WT, McClelland RL et al (2004) Disability profile of MS did not change over 10\u00a0years in a population-based prevalence cohort. Neurology 62:601\u2013606","journal-title":"Neurology"},{"key":"216_CR8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.20197","volume":"56","author":"SJ Pittock","year":"2004","unstructured":"Pittock SJ, McClelland RL, Mayr WT (2004) Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol 56:303\u2013306","journal-title":"Ann Neurol"},{"key":"216_CR9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMoa011341","volume":"346","author":"PA Brex","year":"2002","unstructured":"Brex PA, Ciccarelli O, O\u2019Riordan JI, Sailer M, Thompson AJ, Miller DH (2002) A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 346:158\u2013164","journal-title":"N Engl J Med"},{"key":"216_CR10","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","volume":"359","author":"A Compston","year":"2002","unstructured":"Compston A, Coles A (2002) Multiple sclerosis. Lancet 359:1221\u20131231","journal-title":"Lancet"},{"key":"216_CR11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"C Lucchinetti","year":"2000","unstructured":"Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707\u2013717","journal-title":"Ann Neurol"},{"key":"216_CR12","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","volume":"343","author":"JH Noseworthy","year":"2000","unstructured":"Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938\u2013952","journal-title":"N Engl J Med"},{"key":"216_CR13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/ana.20363","volume":"57","author":"M Tintore","year":"2005","unstructured":"Tintore M, Rovira A, Rio J, Nos C, Grive E, Tellez N et al (2005) Is optic neuritis more benign than other first attacks in multiple sclerosis? Ann Neurol 57:210\u2013215","journal-title":"Ann Neurol"},{"key":"216_CR14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","volume":"13","author":"CM Poser","year":"1983","unstructured":"Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227\u2013231","journal-title":"Ann Neurol"},{"key":"216_CR15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"WI McDonald","year":"2001","unstructured":"McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50:121\u2013127","journal-title":"Ann Neurol"},{"key":"216_CR16","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald criteria\u201d. Ann Neurol 58:840\u2013846","journal-title":"Ann Neurol"},{"key":"216_CR17","first-page":"1165","volume":"27","author":"Y Ge","year":"2006","unstructured":"Ge Y (2006) Multiple sclerosis: the role of MR imaging. AJNR Am J Neuroradiol 27:1165\u20131176","journal-title":"AJNR Am J Neuroradiol"},{"key":"216_CR18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1191\/1352458502ms769oa","volume":"8","author":"MS Freedman","year":"2002","unstructured":"Freedman MS, Blumhardt LD, Brochet B, Comi G, Noseworthy JH, Sandberg-Wollheim M et al (2002) International consensus statement on the use of disease-modifying agents in multiple sclerosis. Mult Scler 8:19\u201323","journal-title":"Mult Scler"},{"key":"216_CR19","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(98)10039-9","volume":"352","author":"European Study Group on interferon beta-1b in secondary progressive MS","year":"1998","unstructured":"European Study Group on interferon beta-1b in secondary progressive MS (1998) Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. Lancet 352:1491\u20131497","journal-title":"Lancet"},{"issue":"8 Suppl 4","key":"216_CR20","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1212\/WNL.58.8_suppl_4.S10","volume":"58","author":"PA Calabresi","year":"2002","unstructured":"Calabresi PA (2002) Considerations in the treatment of relapsing-remitting multiple sclerosis. Neurology 58(8 Suppl 4):S10\u2013S22","journal-title":"Neurology"},{"key":"216_CR21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.wco.0000169742.37159.e9","volume":"18","author":"X Montalban","year":"2005","unstructured":"Montalban X (2005) Primary progressive multiple sclerosis. Curr Opin Neurol 18:261\u2013266","journal-title":"Curr Opin Neurol"},{"key":"216_CR22","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1212\/WNL.52.4.839","volume":"52","author":"VL Stevenson","year":"1999","unstructured":"Stevenson VL, Miller DH, Rovaris M, Barkhof F, Brochet B, Dousset V et al (1999) Primary and transitional progressive MS: a clinical and MRI cross-sectional study. Neurology 52:839\u2013845","journal-title":"Neurology"},{"key":"216_CR23","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/1531-8249(200006)47:6<831::AID-ANA21>3.0.CO;2-H","volume":"47","author":"AJ Thompson","year":"2000","unstructured":"Thompson AJ, Montalban X, Barkhof F, Brochet B, Filippi M, Miller DH et al (2000) Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 47:831\u2013835","journal-title":"Ann Neurol"},{"key":"216_CR24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00019052-200206000-00003","volume":"15","author":"F Barkhof","year":"2002","unstructured":"Barkhof F (2002) The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 15:239\u2013245","journal-title":"Curr Opin Neurol"},{"key":"216_CR25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1212\/WNL.60.1.44","volume":"60","author":"SM Leary","year":"2003","unstructured":"Leary SM, Miller DH, Stevenson VL, Brex PA, Chard DT, Thompson AJ (2003) Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial. Neurology 60:44\u201351","journal-title":"Neurology"},{"key":"216_CR26","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/jnnp.53.10.918","volume":"53","author":"MD Johnson","year":"1990","unstructured":"Johnson MD, Lavin P, Whetsell WO Jr (1990) Fulminant monophasic multiple sclerosis, Marburg\u2019s type. J Neurol Neurosurg Psychiatry 53:918\u2013921","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"216_CR27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/135245859900500302","volume":"5","author":"A Bitsch","year":"1999","unstructured":"Bitsch A, Wegener C, da Costa C, Bunkowski S, Reimers CD, Prange HW, Bruck W (1999) Lesion development in Marburg\u2019s type of acute multiple sclerosis: from inflammation to demyelination. Mult Scler 5:138\u2013146","journal-title":"Mult Scler"},{"issue":"Suppl 4","key":"216_CR28","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.1007\/s10072-004-0341-1","volume":"25","author":"E Capello","year":"2004","unstructured":"Capello E, Mancardi GL (2004) Marburg type and Balo\u2019s concentric sclerosis: rare and acute variants of multiple sclerosis. Neurol Sci 25 (Suppl 4):S361\u2013S363","journal-title":"Neurol Sci"},{"key":"216_CR29","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1212\/WNL.43.6.1100","volume":"43","author":"M Rodriguez","year":"1993","unstructured":"Rodriguez M, Karnes WE, Bartleson JD, Pineda AA (1993) Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. Neurology 43:1100\u20131104","journal-title":"Neurology"},{"key":"216_CR30","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q","volume":"46","author":"BG Weinshenker","year":"1999","unstructured":"Weinshenker BG, O\u2019Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW et al (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46:878\u2013886","journal-title":"Ann Neurol"},{"key":"216_CR31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1552-6569.2004.tb00217.x","volume":"14","author":"DR Jeffery","year":"2004","unstructured":"Jeffery DR, Lefkowitz DS, Crittenden JP (2004) Treatment of Marburg variant multiple sclerosis with mitoxantrone. J Neuroimaging 14:58\u201362","journal-title":"J Neuroimaging"},{"key":"216_CR32","first-page":"589","volume":"137","author":"F Lhermitte","year":"1981","unstructured":"Lhermitte F, Escourolle R, Hauw JJ, Gray F, Serdaru M, Lyon-Caen O (1981) Necrotic aspects of multiple sclerosis and Schilder\u2019s disease. Rev Neurol (Paris) 137:589\u2013600","journal-title":"Rev Neurol (Paris)"},{"key":"216_CR33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000028695","volume":"29","author":"PC Garell","year":"1998","unstructured":"Garell PC, Menezes AH, Baumbach G et al (1998) Presentation, management and follow-up of Schilder\u2019s disease. Pediatr Neurosurg 29:86\u201391","journal-title":"Pediatr Neurosurg"},{"key":"216_CR34","first-page":"176","volume":"10","author":"MF Mehler","year":"1989","unstructured":"Mehler MF, Rabinowich L (1989) Inflammatory myelinoclastic diffuse sclerosis (Schilder\u2019s disease): neuroradiologic findings. AJNR Am J Neuroradiol 10:176\u2013180","journal-title":"AJNR Am J Neuroradiol"},{"key":"216_CR35","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00415-003-1105-1","volume":"250","author":"J Sastre-Garriga","year":"2003","unstructured":"Sastre-Garriga J, Rovira A, Rio J, Tintore M, Grive E, Montalban X (2003) Clinically definite multiple sclerosis after radiological Schilder-like onset. J Neurol 250:871\u2013873","journal-title":"J Neurol"},{"key":"216_CR36","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.41.2_Part_1.316","volume":"41","author":"LP Dresser","year":"1991","unstructured":"Dresser LP, Tourian AY, Anthony DC (1991) A case of myelinoclastic diffuse sclerosis in an adult. Neurology 41:316\u2013318","journal-title":"Neurology"},{"key":"216_CR37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.41.4.589","volume":"41","author":"F Eblen","year":"1991","unstructured":"Eblen F, Poremba M, Grodd W, Opitz H, Roggendorf W, Dichgans J (1991) Myelinoclastic diffuse sclerosis (Schilder\u2019s disease): cliniconeuroradiologic correlations. Neurology 41:589\u2013591","journal-title":"Neurology"},{"key":"216_CR38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/088307389801300501","volume":"13","author":"ML Pretorius","year":"1998","unstructured":"Pretorius ML, Loock DB, Ravenscroft A, Schoeman JF (1998) Demyelinating disease of Schilder type in three young South African children: dramatic response to corticosteroids. J Child Neurol 13:197\u2013201","journal-title":"J Child Neurol"},{"key":"216_CR39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.410350105","volume":"35","author":"DL Yao","year":"1994","unstructured":"Yao DL, Webster HD, Hudson LD, Brenner M, Liu DS, Escobar AI et al (1994) Concentric sclerosis (Balo): morphometric and in situ hybridization study of lesions in six patients. Ann Neurol 35:18\u201330","journal-title":"Ann Neurol"},{"key":"216_CR40","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1148\/radiology.191.3.8184071","volume":"191","author":"AM Gharagozloo","year":"1994","unstructured":"Gharagozloo AM, Poe LB, Collins GH (1994) Antemortem diagnosis of Balo concentric sclerosis: correlative MR imaging and pathologic features. Radiology 191:817\u2013819","journal-title":"Radiology"},{"key":"216_CR41","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/brain\/awh457","volume":"128","author":"C Stadelmann","year":"2005","unstructured":"Stadelmann C, Ludwin S, Tabira T, Guseo A, Luchinetti CF, Leel-Ossy L et al (2005) Tissue preconditioning may explain concentric lesions in Bal\u00f3\u2019s type of multiple sclerosis. Brain 128:979\u2013987","journal-title":"Brain"},{"key":"216_CR42","first-page":"1284","volume":"15","author":"JH Korte","year":"1994","unstructured":"Korte JH, Bom EP, Vos LD, Breuer TJ, Wondergem JH (1994) Balo concentric sclerosis: MR diagnosis. AJNR Am J Neuroradiol 15:1284\u20131285","journal-title":"AJNR Am J Neuroradiol"},{"key":"216_CR43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000084264","volume":"53","author":"H Wiendl","year":"2005","unstructured":"Wiendl H, Weissert R, Herrlinger U, Krapf H, Kuker W (2005) Diffusion abnormality in Balo\u2019s concentric sclerosis: clues for the pathogenesis. Eur Neurol 53:42\u201344","journal-title":"Eur Neurol"},{"key":"216_CR44","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archneur.62.11.1673","volume":"62","author":"T Menge","year":"2005","unstructured":"Menge T, Hemmer B, Nessler S, Wiendl H, Neuhaus O, Hartung HP et al (2005) Acute disseminated encephalomyelitis: an update. Arch Neurol 62:1673\u20131680","journal-title":"Arch Neurol"},{"key":"216_CR45","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/brain\/123.12.2407","volume":"123","author":"RC Dale","year":"2000","unstructured":"Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG (2000) Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 123:2407\u20132422","journal-title":"Brain"},{"key":"216_CR46","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1212\/WNL.56.10.1308","volume":"56","author":"JL Hynson","year":"2001","unstructured":"Hynson JL, Kornberg AJ, Coleman LT, Shield L, Harvey AS, Kean MJ (2001) Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 56:1308\u20131312","journal-title":"Neurology"},{"key":"216_CR47","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1212\/WNL.59.8.1224","volume":"59","author":"S Tenembaum","year":"2002","unstructured":"Tenembaum S, Chamoles N, Fejerman N (2002) Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 59:1224\u20131231","journal-title":"Neurology"},{"key":"216_CR48","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/adc.2004.062935","volume":"90","author":"RC Dale","year":"2005","unstructured":"Dale RC, Branson JA (2005) Acute disseminated encephalomyelitis or multiple sclerosis: can the initial presentation help in establishing a correct diagnosis? Arch Dis Child 90:636\u2013639","journal-title":"Arch Dis Child"},{"key":"216_CR49","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF00588134","volume":"36","author":"KS Caldemeyer","year":"1994","unstructured":"Caldemeyer KS, Smith RR, Harris TM, Edwards MK (1994) MRI in acute disseminated encephalomyelitis. Neuroradiology 36:216\u2013220","journal-title":"Neuroradiology"},{"key":"216_CR50","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/brain\/113.2.291","volume":"113","author":"J Kesselring","year":"1990","unstructured":"Kesselring J, Miller DH, Robb SA, Kendall BE, Moseley IF, Kingsley D et al (1990) Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis. Brain 113:291\u2013302","journal-title":"Brain"},{"key":"216_CR51","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0022-510X(99)00160-4","volume":"167","author":"JI O\u2019Riordan","year":"1999","unstructured":"O\u2019Riordan JI, Gomez-Anson B, Moseley IF, Miller DH (1999) Long term MRI follow-up of patients with post infectious encephalomyelitis: evidence for a monophasic disease. J Neurol Sci 167:132\u2013136","journal-title":"J Neurol Sci"},{"key":"216_CR52","first-page":"1117","volume":"22","author":"J Honkaniemi","year":"2001","unstructured":"Honkaniemi J, Dastidar P, Kahara V, Haapasalo H (2001) Delayed MR imaging changes in acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 22:1117\u20131124","journal-title":"AJNR Am J Neuroradiol"},{"key":"216_CR53","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1093\/brain\/awh218","volume":"127","author":"Y Mikaeloff","year":"2004","unstructured":"Mikaeloff Y, Adamsbaum C, Husson B, Vallee L, Ponsot G, Confavreux C et al (2004) MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain 127:1942\u20131947","journal-title":"Brain"},{"issue":"Suppl 1","key":"216_CR54","first-page":"S23","volume":"16","author":"L Krupp","year":"2006","unstructured":"Krupp L, MacAllister W; on behalf of the International Pediatric MS Study Group (2006) Consensus definitions of acquired CNS demyelinating disorders of childhood. Mult Scler 16 [Suppl 1]:S23","journal-title":"Mult Scler 16[Suppl 1]:S23"},{"key":"216_CR55","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1212\/WNL.56.10.1257","volume":"56","author":"HP Hartung","year":"2001","unstructured":"Hartung HP, Grossman RI (2001) ADEM: distinct disease or part of the MS spectrum? Neurology 56:1257\u20131260","journal-title":"Neurology"},{"key":"216_CR56","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/08830738020170111001","volume":"17","author":"E Shahar","year":"2002","unstructured":"Shahar E, Andraus J, Savitzki D, Pilar G, Zelnik N (2002) Outcome of severe encephalomyelitis in children: effect of high-dose methylprednisolone and immunoglobulins. J Child Neurol 17:810\u2013814","journal-title":"J Child Neurol"},{"key":"216_CR57","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1212\/WNL.58.1.143","volume":"58","author":"M Keegan","year":"2002","unstructured":"Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG (2002) Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 58:143\u2013146","journal-title":"Neurology"},{"key":"216_CR58","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/PL00007836","volume":"249","author":"E Marchioni","year":"2002","unstructured":"Marchioni E, Marinou-Aktipi K, Uggetti C, Bottanelli M, Pichiecchio A, Soragna D et al (2002) Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis. J Neurol 249:100\u2013104","journal-title":"J Neurol"},{"key":"216_CR59","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0387-7604(99)00011-X","volume":"21","author":"RA Apak","year":"1999","unstructured":"Apak RA, Anlar B, Saatci I (1999) A case of relapsing acute disseminated encephalomyelitis with high dose corticosteroid treatment. Brain Dev 21:279\u2013282","journal-title":"Brain Dev"},{"key":"216_CR60","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1212\/WNL.56.10.1313","volume":"56","author":"S Schwarz","year":"2001","unstructured":"Schwarz S, Mohr A, Knauth M, Wildemann B, Storch-Hagenlocher B (2001) Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 56:1313\u20131318","journal-title":"Neurology"},{"key":"216_CR61","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/01.rct.0000173843.82364.db","volume":"29","author":"WN Gibbs","year":"2005","unstructured":"Gibbs WN, Kreidie MA, Kim RC, Hasso AN (2005) Acute hemorrhagic leukoencephalitis: neuroimaging features and neuropathologic diagnosis. J Comput Assist Tomogr 29:689\u2013693","journal-title":"J Comput Assist Tomogr"},{"key":"216_CR62","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00000478-199306000-00001","volume":"17","author":"D Zagzag","year":"1993","unstructured":"Zagzag D, Miller DC, Kleinman GM, Abati A, Donnenfeld H, Budzilovich GN (1993) Demyelinating disease versus tumor in surgical neuropathology. Clues to a correct pathological diagnosis. Am J Surg Pathol 17:537\u2013545","journal-title":"Am J Surg Pathol"},{"key":"216_CR63","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.410330105","volume":"33","author":"JJ Kepes","year":"1993","unstructured":"Kepes JJ (1993) Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol 33:18\u201327","journal-title":"Ann Neurol"},{"key":"216_CR64","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/BF00626098","volume":"38","author":"AP Dagher","year":"1996","unstructured":"Dagher AP, Smirniotopoulos J (1996) Tumefactive demyelinating lesions. Neuroradiology 38:560\u2013565","journal-title":"Neuroradiology"},{"key":"216_CR65","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2214\/ajr.182.1.1820195","volume":"182","author":"CA Given","year":"2004","unstructured":"Given CA, Stevens BS, Lee C (2004) The MRI appearance of tumefactive demyelinating lesions. AJR Am J Roentgenol 182:195\u2013199","journal-title":"AJR Am J Roentgenol"},{"key":"216_CR66","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/nbm.772","volume":"15","author":"MG Cucurella","year":"2002","unstructured":"Cucurella MG, Rovira A, Griv\u00e9 E, Tintor\u00e9 M, Montalban X, Alonso J (2002) Serial proton spectroscopy, magnetization transfer ratio and T2 relaxation in pseudotumoral demyelinating lesions. NMR Biomed 15:284\u2013292","journal-title":"NMR Biomed"},{"key":"216_CR67","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1212\/WNL.54.7.1427","volume":"54","author":"JC Masdeu","year":"2000","unstructured":"Masdeu JC, Quinto C, Olivera C, Tenner M, Leslie D, Visintainer P (2000) Open-ring imaging sign: highly specific for atypical brain demyelination. Neurology 54:1427\u20131433","journal-title":"Neurology"},{"key":"216_CR68","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00234-005-0024-5","volume":"48","author":"KM Schwartz","year":"2006","unstructured":"Schwartz KM, Erickson BJ, Lucchinetti C (2006) Pattern of T2 hypointensity associated with ring-enhancing brain lesions can help to differentiate pathology. Neuroradiology 48:143\u2013149","journal-title":"Neuroradiology"},{"key":"216_CR69","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s00234-002-0872-1","volume":"44","author":"M Law","year":"2002","unstructured":"Law M, Meltzer DE, Cha S (2002) Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion. Neuroradiology 44:986\u2013989","journal-title":"Neuroradiology"},{"key":"216_CR70","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1259\/bjr\/85069069","volume":"76","author":"DJ Butteriss","year":"2003","unstructured":"Butteriss DJ, Ismail A, Ellison DW, Birchall D (2003) Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis. Br J Radiol 76:662\u2013665","journal-title":"Br J Radiol"},{"key":"216_CR71","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/ana.410440222","volume":"44","author":"N De Stefano","year":"1998","unstructured":"De Stefano N, Caramanos Z, Preul MC, Francis G, Antel JP, Arnold DL (1998) In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging. Ann Neurol 44:273\u2013278","journal-title":"Ann Neurol"},{"key":"216_CR72","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1212\/WNL.59.7.1074","volume":"59","author":"Y Mao-Draayer","year":"2002","unstructured":"Mao-Draayer Y, Braff S, Pendlebury W, Panitch H (2002) Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange. Neurology 59:1074\u20131077","journal-title":"Neurology"},{"key":"216_CR73","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O\u2019Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology 53:1107\u20131114","journal-title":"Neurology"},{"key":"216_CR74","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archopht.121.7.944","volume":"121","author":"RW Beck","year":"2003","unstructured":"Beck RW, Trobe JD, Moke PS, Gal RL, Xing D, Bhatti MT et al (2003) High- and low-risk profiles for the development of multiple sclerosis within 10\u00a0years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 121:944\u2013949","journal-title":"Arch Ophthalmol"},{"key":"216_CR75","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1191\/1352458505ms1213oa","volume":"11","author":"MA Rocca","year":"2005","unstructured":"Rocca MA, Hickman SJ, B\u00f6 L, Agosta F, Miller DH, Comi G et al (2005) Imaging the optic nerve in multiple sclerosis. Mult Scler 11:537\u2013541","journal-title":"Mult Scler"},{"key":"216_CR76","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF00596577","volume":"38","author":"A Gass","year":"1996","unstructured":"Gass A, Moseley IF, Barker GJ, Jones S, MacManus D, McDonald WI, Miller DH (1996) Lesion discrimination in optic neuritis using high-resolution fat-suppressed fast spin-echo MRI. Neuroradiology 38:317\u2013321","journal-title":"Neuroradiology"},{"key":"216_CR77","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00234-004-1308-x","volume":"47","author":"SJ Hickman","year":"2005","unstructured":"Hickman SJ, Miszkiel KA, Plant GT, Miller DH (2005) The optic nerve sheath on MRI in acute optic neuritis. Neuroradiology 47:51\u201355","journal-title":"Neuroradiology"},{"key":"216_CR78","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/brain\/awf087","volume":"125","author":"MJ Kupersmith","year":"2002","unstructured":"Kupersmith MJ, Alban T, Zeiffer B, Lefton D (2002) Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. Brain 125:812\u2013822","journal-title":"Brain"},{"key":"216_CR79","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s002340050681","volume":"40","author":"MB Davies","year":"1998","unstructured":"Davies MB, Williams R, Haq N, Pelosi L, Hawkins CP (1998) MRI of optic nerve and postchiasmal visual pathways and visual evoked potentials in secondary progressive multiple sclerosis. Neuroradiology 40:765\u2013770","journal-title":"Neuroradiology"},{"key":"216_CR80","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410260508","volume":"26","author":"DH Miller","year":"1989","unstructured":"Miller DH, Ormerod IE, Rudge P, Kendall BE, Moseley IF, McDonald WI (1989) The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord. Ann Neurol 26:635\u2013639","journal-title":"Ann Neurol"},{"key":"216_CR81","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1191\/1352458503ms847oa","volume":"9","author":"J Sastre-Garriga","year":"2003","unstructured":"Sastre-Garriga J, Tintore M, Rovira A, Grive E, Pericot I, Comabella M et al (2003) Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings. Mult Scler 9:39\u201343","journal-title":"Mult Scler"},{"key":"216_CR82","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/bmj.2.4723.77","volume":"4723","author":"ER Bickerstaff","year":"1951","unstructured":"Bickerstaff ER, Cloake PC (1951) Mesencephalitis and rhombencephalitis. Br Med J 4723:77\u201381","journal-title":"Br Med J"},{"key":"216_CR83","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0022-510X(90)90054-Q","volume":"96","author":"BA Yaqub","year":"1990","unstructured":"Yaqub BA, al-Deeb SM, Daif AK, Sharif HS, Shamena AR, al-Jaberi M et al (1990) Bickerstaff brainstem encephalitis. A grave non-demyelinating disease with benign prognosis. J Neurol Sci 96:29\u201340","journal-title":"J Neurol Sci"},{"key":"216_CR84","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1468-1331.2003.00502_1.x","volume":"10","author":"VL Stevenson","year":"2003","unstructured":"Stevenson VL, Ferguson SM, Bain PG (2003) Bickerstaff\u2019s brainstem encephalitis, Miller Fisher syndrome and Guillain-Barre syndrome overlap with negative anti-GQ1b antibodies. Eur J Neurol 10:187","journal-title":"Eur J Neurol"},{"key":"216_CR85","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/jnnp.71.4.433","volume":"71","author":"JB Winer","year":"2001","unstructured":"Winer JB (2001) Bickerstaff\u2019s encephalitis and the Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 71:433\u2013435","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"216_CR86","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00234-001-0733-3","volume":"44","author":"RR Mondejar","year":"2002","unstructured":"Mondejar RR, Santos JM, Villalba EF (2002) MRI findings in a remitting-relapsing case of Bickerstaff encephalitis. Neuroradiology 44:411\u2013414","journal-title":"Neuroradiology"},{"key":"216_CR87","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/WNL.59.4.499","volume":"59","author":"Transverse Myelitis Consortium Working Group","year":"2002","unstructured":"Transverse Myelitis Consortium Working Group (2002) Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 59:499\u2013505","journal-title":"Neurology"},{"key":"216_CR88","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1474-4422(03)00504-0","volume":"2","author":"G Lycklama","year":"2003","unstructured":"Lycklama G, Thompson A, Filippi M, Miller D, Polman C, Fazekas F et al (2003) Spinal-cord MRI in multiple sclerosis. Lancet Neurol 2:555\u2013562","journal-title":"Lancet Neurol"},{"key":"216_CR89","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s002340000429","volume":"42","author":"JL Dietemann","year":"2000","unstructured":"Dietemann JL, Thibaut-Menard A, Warter JM, Neugroschl C, Tranchant C, Gillis C, Eid MA, Bogorin A (2000) MRI in multiple sclerosis of the spinal cord: evaluation of fast short-tau inversion-recovery and spin-echo sequences. Neuroradiology 42:810\u2013813","journal-title":"Neuroradiology"},{"key":"216_CR90","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s002340000368","volume":"42","author":"A Campi","year":"2000","unstructured":"Campi A, Pontesilli S, Gerevini S, Scotti G (2000) Comparison of MRI pulse sequences for investigation of lesions of the cervical spinal cord. Neuroradiology 42:669\u2013675","journal-title":"Neuroradiology"},{"key":"216_CR91","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00415-004-0271-0","volume":"251","author":"A Ghezzi","year":"2004","unstructured":"Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E et al (2004) Clinical characteristics, course and prognosis of relapsing Devic\u2019s neuromyelitis optica. J Neurol 251:47\u201352","journal-title":"J Neurol"},{"key":"216_CR92","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1001\/archneur.60.9.1336","volume":"60","author":"J de Seze","year":"2003","unstructured":"de Seze J (2003) Neuromyelitis optica. Arch Neurol 60:1336\u20131338","journal-title":"Arch Neurol"},{"key":"216_CR93","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106\u20132112","journal-title":"Lancet"},{"key":"216_CR94","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1212\/WNL.53.8.1705","volume":"53","author":"M Filippi","year":"1999","unstructured":"Filippi M, Rocca MA, Moiola L et al (1999) MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic\u2019s neuromyelitis optica. Neurology 53:1705\u20131710","journal-title":"Neurology"},{"key":"216_CR95","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1212\/01.WNL.0000106946.08741.41","volume":"62","author":"MA Rocca","year":"2004","unstructured":"Rocca MA, Agosta F, Mezzapesa DM et al (2004) Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica. Neurology 62:476\u2013478","journal-title":"Neurology"},{"key":"216_CR96","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ana.410340211","volume":"34","author":"RN Mandler","year":"1993","unstructured":"Mandler RN, Davis LE, Jeffery DR, Kornfeld M (1993) Devic\u2019s neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 34:162\u2013168","journal-title":"Ann Neurol"},{"key":"216_CR97","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/jnnp.60.4.382","volume":"60","author":"JI O\u2019Riordan","year":"1996","unstructured":"O\u2019Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DP, Thompson EJ et al (1996) Clinical, CSF, and MRI findings in Devic\u2019s neuromyelitis optica. J Neurol Neurosurg Psychiatry 60:382\u2013387","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"216_CR98","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473\u2013477","journal-title":"J Exp Med"},{"key":"216_CR99","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.20770","volume":"59","author":"BG Weinshenker","year":"2006","unstructured":"Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF et al (2006) Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59:566\u2013569","journal-title":"Ann Neurol"},{"key":"216_CR100","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485\u20131489","journal-title":"Neurology"},{"key":"216_CR101","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11940-005-0010-6","volume":"7","author":"DM Wingerchuk","year":"2005","unstructured":"Wingerchuk DM, Weinshenker BG (2005) Neuromyelitis optica. Curr Treat Options Neurol 7:173\u2013182","journal-title":"Curr Treat Options Neurol"},{"key":"216_CR102","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.51.4.1219","volume":"51","author":"RN Mandler","year":"1998","unstructured":"Mandler RN, Ahmed W, Dencoff JE (1998) Devic\u2019s neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 51:1219\u20131220","journal-title":"Neurology"},{"key":"216_CR103","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","volume":"64","author":"BA Cree","year":"2005","unstructured":"Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64:1270\u20131272","journal-title":"Neurology"},{"key":"216_CR104","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1212\/WNL.49.5.1413","volume":"49","author":"CF Lucchinetti","year":"1997","unstructured":"Lucchinetti CF, Kiers L, O\u2019Duffy A, Gomez MR, Cross S, Leavitt JA et al (1997) Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology 49:1413\u20131418","journal-title":"Neurology"},{"key":"216_CR105","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archneur.61.9.1401","volume":"61","author":"I Pirko","year":"2004","unstructured":"Pirko I, Blauwet LK, Lesnick TG, Weinshenker BG (2004) The natural history of recurrent optic neuritis. Arch Neurol 61:1401\u20131405","journal-title":"Arch Neurol"},{"key":"216_CR106","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1212\/01.WNL.0000049912.02954.2C","volume":"60","author":"DM Wingerchuk","year":"2003","unstructured":"Wingerchuk DM, Weinshenker BG (2003) Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 60:848\u2013853","journal-title":"Neurology"},{"key":"216_CR107","first-page":"1290","volume":"60","author":"KK Kim","year":"2003","unstructured":"Kim KK (2003) Idiopathic recurrent transverse myelitis. Arch Neurol 60:1290\u20131294","journal-title":"Arch Neurol"},{"key":"216_CR108","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.clineuro.2004.05.001","volume":"107","author":"KH Chan","year":"2005","unstructured":"Chan KH, Tsang KL, Fong GC, Cheung RT, Ho SL (2005) Idiopathic severe recurrent transverse myelitis: a restricted variant of neuromyelitis optica. Clin Neurol Neurosurg 107:132\u2013135","journal-title":"Clin Neurol Neurosurg"},{"key":"216_CR109","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1212\/WNL.38.2.180","volume":"38","author":"DW Paty","year":"1988","unstructured":"Paty DW, Oger JJ, Kastrukoff LF, Hashimoto SA, Hooge JP, Eisen AA, Eisen KA, Purves SJ, Low MD, Brandejs V et al (1988) MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38:180\u2013185","journal-title":"Neurology"}],"container-title":["Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-007-0216-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00234-007-0216-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-007-0216-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-007-0216-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T01:18:44Z","timestamp":1652836724000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00234-007-0216-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,28]]},"references-count":109,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["216"],"URL":"https:\/\/doi.org\/10.1007\/s00234-007-0216-2","relation":{},"ISSN":["0028-3940","1432-1920"],"issn-type":[{"value":"0028-3940","type":"print"},{"value":"1432-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,28]]},"assertion":[{"value":"10 November 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}